Debt (Details) - USD ($)								1 Months Ended			12 Months Ended
	Jul. 14, 2023	Jan. 09, 2023	Nov. 04, 2022	Jan. 01, 2022	May 14, 2020	Dec. 27, 2019	Oct. 11, 2017	May 31, 2023	May 31, 2022	Mar. 31, 2022	Dec. 31, 2023	Dec. 31, 2022	Jul. 13, 2023	May 11, 2023	Apr. 30, 2023	Apr. 23, 2023	Mar. 31, 2023	Jan. 31, 2023	Apr. 24, 2019
Debt [Line Items]
Debenture																			$ 3,000,000
Knight Loan amount												$ 20,596,595
Maturity days											30 days
Excess fair value discount											$ 120,683
Note and incurred costs											1,767
Amortization discount											52,628	4,955
Interest expense											$ 66,558	115,546
Converted shares (in Shares)										214,934	79,926
Debt extinguishment gain										$ 223,077
Original issue discount											$ 10,128,500
Debt issuance costs																			2,100,000
Company issued holders common stock (in Shares)													31,447
Debt extinguishment loss											614,670
Additional cash payments due to the holders								$ 8,472
Conversion rate, percentage								90.00%
Accumulated interest												1,555,670
Gross proceeds											$ 6,454,325
Initial public offering discount, percentages											15.00%
Common stock outstanding, percentages											19.90%
Milestone payment											$ 10,000,000
Regulatory advice value											$ 30,000
Cumulative dividend											6.00%
Common stock ownership percentage											19.90%
Equal royalty pay to lender, percentage				$ 3.5
Extinguishment amount		$ 839,887									$ (1,231,480)	120,683
Description of knight debt conversion agreement											As a result of the completion of the IPO and as required under the terms of the Knight Debt Conversion Agreement, the cumulative outstanding principal as of March 31, 2022 converted to 1,108,337 shares of common stock (representing 19.9% ownership of the Company’s common stock after giving effect to the IPO). In addition, the entirety of the accumulated interest as of March 31, 2022 converted into 80,965 shares of Series A Preferred Stock at the conversion rate detailed above, in full satisfaction of the Company’s obligations with respect to the accumulated interest. Upon consummation of the IPO and under the terms of the Knight Debt Conversion Agreement, the Company became obligated to the contingent milestone payments and the accumulated Royalty discussed above, which value was included in the reacquisition price of the debt upon extinguishment. The Company recognized a final mark-to-market adjustment of $6,105,066 to adjust the Convertible Knight Loan to its fair value on the date of settlement, and as a result, no gain or loss was recognized on the debt extinguishment.
Unamortized original issue discount											$ 0	279,061
Interest payments			$ 731								179,117	2,193
Long-term debt, current maturities											8,772	2,750
Long-term liability											150,251	1,525,055
Current maturity												2,750
Long-term liability amount											150,251	160,272
Short term advance														$ 250,000	$ 50,000		$ 200,000
IPO [Member]
Debt [Line Items]
Accrued interest											$ 31,968
Fully vested warrants exercise price percentage								110.00%
Company issued holders common stock (in Shares)	1,415,095
Conversion rate, percentage								20.00%
Conversion rate, percentage											80.00%
Gross proceeds	$ 6,454,325										$ 7,000,000
Preferred Stock [Member]
Debt [Line Items]
Accumulated interest											100
Chief Executive Officer [Member]
Debt [Line Items]
Promissory notes face amount									$ 338,889
Discount rate									10.00%
Original issue discount									$ 33,888
Debt issuance costs									34,289
Net proceeds									$ 270,711
Notes bear interest									6.00%
Default interest rate									15.00%
Knight Therapeutics, Inc. [Member]
Debt [Line Items]
Principal amount						$ 6,309,823
Accrued interest						4,160,918
Debenture						$ 3,483,851
Annual interest rate																15.00%
Debenture interest rate																9.00%
Promissory Note [Member]
Debt [Line Items]
Promissory note							$ 750,000
Interest rate							5.00%
Note [Member]
Debt [Line Items]
Annual interest rate							10.00%
2022 Bridge Notes [Member]
Debt [Line Items]
Principal amount												888,889
Accrued interest											$ 1,749,488
Interest rate											10.00%
Promissory notes face amount									$ 888,889
Discount rate									10.00%
Original issue discount									$ 88,889
Debt issuance costs									91,436
Net proceeds									$ 708,564
Notes bear interest									10.00%
Default interest rate									15.00%
Face amount, percentage									100.00%
Additional cash payments								$ 22,222
Balloon payment											$ 28,154
2022 Bridge Notes [Member] | IPO [Member]
Debt [Line Items]
Fully vested warrants exercise price percentage								110.00%
2023 Bridge Notes [Member]
Debt [Line Items]
Principal amount								$ 722,222
Interest rate											10.00%
Discount rate								10.00%
Original issue discount								$ 72,222
Debt issuance costs								95,000
Net proceeds								$ 555,000
Notes bear interest								10.00%
Default interest rate								15.00%
Face amount, percentage								100.00%
Bridge Notes [Member] | IPO [Member]
Debt [Line Items]
Company issued holders common stock (in Shares)											303,982
Related Party Notes [Member]
Debt [Line Items]
Amortization of debt discounts											$ 670,550	664,780
Knight’s Cumulative Debt [Member]
Debt [Line Items]
Principal amount										10,770,037
Accumulated interest										$ 8,096,486
Debenture [Member]
Debt [Line Items]
Amortized interest expense												500,103							$ 13,696
Small Business Administration [Member]
Debt [Line Items]
Principal amount					$ 150,000
Annual interest rate					3.75%
Committed to monthly payments					$ 731
Principal payments											$ 159,023	$ 163,022
Geoffrey S. Dow Revocable Trust [Member]
Debt [Line Items]
Short term advance																	$ 23,000
Tyrone Miller [Member]
Debt [Line Items]
Company issued holders common stock (in Shares)																	192,101	192,101
Short term advance																	$ 27,000